• Теги
    • избранные теги
    • Компании1933
      • Показать ещё
      Разное427
      • Показать ещё
      Международные организации25
      • Показать ещё
      Страны / Регионы161
      • Показать ещё
      Люди35
      • Показать ещё
      Показатели26
      • Показать ещё
      Формат8
      Сферы3
      Издания9
      • Показать ещё
20 января, 16:45

Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?

Celgene Corporation (CELG), which is set to report fourth-quarter 2016 results on Jan 26, reported a positive earnings surprise of 6.11% last quarter.

18 января, 18:03

4 Top Biotech Mutual Funds for 2017

Biotechnology shares have welcomed this year in style, marking a striking reversal from last year???s dismal performance

17 января, 16:12

Medidata Solutions Clinical Cloud Gets Picked by Celgene

Medidata Solutions Inc. (MDSO) recently announced that Celgene Corporation adopted Medidata Clinical Cloud.

Выбор редакции
12 января, 16:46

BRIEF-Medidata Solutions says Celgene increased adoption of Medidata Clinical Cloud

* Medidata Solutions - Celgene increases adoption of Medidata Clinical Cloud Source text for Eikon: Further company coverage:

11 января, 17:13

Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short

Several licensing deals and agreements were announced this week including the $5.2 billion ARIAD (ARIA) acquisition.

10 января, 16:55

Celgene Issues Preliminary 2016 Results, Lifts 2017 View

Celgene (CELG) announced preliminary 2016 results and upped guidance for 2017 at the J.P. Morgan Healthcare Conference.

Выбор редакции
06 января, 16:19

Halozyme (HALO) Up on Positive Phase II Data on PEGPH20

Halozyme (HALO) announced top-line data from the combined analysis from its phase II HALO 202 study on PEGPH20.

06 января, 16:17

Bristol-Myers, J&J Ink Immunotherapy Research Collaboration

Bristol-Myers (BMY) entered into an immunotherapy clinical research collaboration with Johnson & Johnson to evaluate a combination of Opdivo and Darzalex.

30 декабря 2016, 17:37

Prima (PBMD) Reports Favorable Initial Melanoma Study Data

Prima (PBMD) announced interim data from the TACTI-mel program on IMP321 for the treatment of patients with unresectable or metastatic melanoma.

29 декабря 2016, 17:30

The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon

The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon

29 декабря 2016, 02:04

Top Research Reports for December 28, 2016

Top Research Reports for December 28, 2016

28 декабря 2016, 17:30

The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech

The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech

28 декабря 2016, 15:32

Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold

Biogen (BIIB) and Ionis got an early Christmas gift with the FDA approving their spinal muscular atrophy drug within three months of regulatory filing.

27 декабря 2016, 16:53

Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead

We advise investors to focus on biotech stocks which sport a strong Zacks Rank and have interesting pipelines/products and growth potential.

23 декабря 2016, 16:45

Celgene's Otezla Gains Positive Recommendation from NICE

Celgene Corporation (CELG) announced that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination, recommending the use of its oral phosphodiesterase 4, Otezla.

22 декабря 2016, 18:10

Stock Market News for December 22, 2016

Benchmarks ended modestly lower on Wednesday, thanks to broad based decline in the health care sector.

Выбор редакции
21 декабря 2016, 18:40

Juno Gets Breakthrough Therapy Status for Lymphoma Drug

Juno Therapeutics, Inc. (JUNO) and partner Celgene Corporation (CELG), announced that the FDA has granted Breakthrough Therapy designation to their investigational candidate, JCAR017.

21 декабря 2016, 16:42

Celgene (CELG) Otezla Approved in Japan for Two Indications

Celgene's (CELG) Otezla approved for the treatment of plaque psoriasis and psoriatic arthritis in Japan.

19 декабря 2016, 16:47

Agios Stops Development of PKR Activator AG-519, Stock Falls

Shares of Agios (AGIO) tanked 19.4% after the company decided to discontinue the development of its PKR activator, AG-519.